The trajectory of Sildenafil presents a nuanced case for observers in the drug sector. While initially a blockbuster success, creating billions, the intellectual property lapse and the subsequent entry of generic https://pharma763119.blogaritma.com/39609090/sildenafil-and-big-pharma-a-hazardous-bet